跳至主要内容
临床试验/NCT07703696
NCT07703696尚未招募不适用

Effectiveness of Psychosocial Counseling on Treatment Adherence Among Patients With a New Tuberculosis Diagnosis in Primary Care: A Study Protocol of a Quasi-experimental Trial

Universitas Diponegoro1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2026年8月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
108
试验地点
1
主要终点
Treatment adherence

研究概览

简要总结

Introduction: Newly diagnosed TB patients frequently experience psychological distress, stigma, and concerns regarding treatment duration, side effects, and social consequences, which may negatively affect adherence. Psychosocial counseling has been proposed as a patient-centered strategy to address these challenges; however, evidence regarding its effectiveness among newly diagnosed TB patients in primary care settings remains limited. This study aims to evaluate the effectiveness of a psychosocial counseling intervention in improving treatment adherence and psychosocial outcomes among newly diagnosed TB patients receiving care in primary health care centers. Methods and Analysis: This study will employ a two-arm quasi-experimental design conducted in 10 primary health care centers (PHCs) in Semarang City, Indonesia. Five PHCs will be allocated to the intervention group and five PHCs to the control group to minimize contamination. A total of 108 newly diagnosed pulmonary TB patients will be recruited. Participants in the intervention group will receive a structured psychosocial counseling program in addition to standard TB care, while participants in the control group will receive standard TB care alone. Data will be collected at baseline (T0), immediately after the intervention (T1), and two months after treatment initiation (T2). The primary outcome is treatment adherence during the intensive phase of treatment. Secondary outcomes include psychological distress, TB-related stigma, TB knowledge, and treatment self-efficacy. Data will be analyzed using descriptive statistics, mixed-design analysis of variance, chi-square tests, and multivariable logistic regression.

详细描述

Introduction Tuberculosis (TB) continues as a major global threat to public health. In 2024, TB is estimated to have infected more than 10 million people in 2024, and 1.23 million died. Indonesia accounts for 10% of the cases, becoming the second-highest country with a TB burden after India (25%)[1]. Despite ongoing efforts to strengthen TB control, treatment adherence remains a major challenge in Indonesia. Poor adherence to anti-tuberculosis treatment contributes to treatment failure, disease recurrence, and the emergence of drug-resistant tuberculosis. Indonesia remains among the countries with the highest burden of multidrug-resistant tuberculosis (MDR-TB), with 7.3% accounted for global cases in 2024 [1]. Although 73% of patients initiated treatment, only 55% completed the treatment course, indicating substantial gaps in treatment retention and continuity of care [2].

The challenges of TB treatment extend beyond clinical and pharmacological factors. Patients newly diagnosed with TB frequently experience psychological distress, including fear, anxiety, stigma, social isolation, and concerns about treatment duration and side effects [3-5]. Studies found that psychological distress affects nearly half of TB patients, with a pooled prevalence of 47.5% reported [6]. Anxiety is also common, affecting approximately 32.5% of patients, while depression has been reported in about 45.2% of individuals undergoing TB treatment [7,8]. Furthermore, TB-related stigma remains a significant psychosocial burden, contributing to social withdrawal, delayed health-seeking behavior, and poor treatment adherence.

The standard treatment regimen that requires at least six months of continuous medication demands substantial behavioral commitment and social support. These psychosocial burdens may negatively affect patients' motivation, self-efficacy, and treatment adherence, which compromises treatment outcomes. Previous studies have demonstrated that psychosocial factors substantially influence TB treatment outcomes. Depression has been associated with an increased risk of negative treatment outcomes, including loss to follow-up and mortality. A systematic review reported that patients with depressive symptoms had 8.7 times fold higher odds of loss to follow-up during treatment [9]. In addition, perceived stigma and inadequate social support have been consistently identified as barriers to treatment adherence and retention in care [10,11]. Therefore, addressing psychosocial factors is an essential component of comprehensive TB care.

Psychosocial counseling has been recognized as a promising strategy to support individuals coping with chronic illnesses by enhancing emotional well-being, strengthening coping mechanisms, and promoting health-related behaviors [12,13]. In the context of tuberculosis, counseling interventions may help patients understand their disease, manage treatment-related concerns, reduce stigma, and build confidence to complete treatment [14]. Despite growing recognition of the importance of patient-centered care, evidence regarding the effectiveness of psychosocial counseling for newly diagnosed TB patients in primary care settings remains limited, particularly in low- and middle-income countries such as Indonesia. Evaluating such interventions is therefore important for informing evidence-based strategies to improve treatment adherence and patient outcomes. This study aims to evaluate the effectiveness of a psychosocial counseling intervention among newly diagnosed tuberculosis patients receiving treatment in primary care compared with standard care. The intervention is guided by the Health Belief Model (HBM) and Social Cognitive Theory (SCT), which suggest that treatment adherence is influenced by patients' perceptions of disease severity and susceptibility, perceived benefits and barriers to treatment, self-efficacy, and social support. These theoretical constructs are incorporated into the counseling sessions to enhance patients' understanding of tuberculosis, strengthen coping strategies, reduce stigma-related concerns, and improve confidence in completing treatment.

Methods Study design and setting This study will employ a two-arm quasi-experimental design to evaluate the effectiveness of a psychosocial counseling intervention among newly diagnosed TB patients receiving treatment in primary care settings [15]. The study will be conducted over 2 months in 10 primary health care centers (PHCs) in Semarang City, Central Java, Indonesia. The participating PHCs will be selected based on having the highest TB case notifications in the city.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
17 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be adults aged 18 years and older with a newly confirmed diagnosis of pulmonary tuberculosis who are scheduled to initiate anti-tuberculosis treatment at the participating PHCs

排除标准

  • diagnosed with multidrug-resistant tuberculosis (MDR-TB), have severe cognitive impairment or psychiatric disorders that may affect their ability to participate in counseling sessions and study assessments, or have serious medical conditions requiring hospitalization at the time of recruitment.

研究组 & 干预措施

Intervention group

Experimental

The intervention is delivered individually in a face-to-face format by trained counselors holding at least a bachelor's degree in public health who have received specific training on the counseling protocol and TB patient support. A standardized counseling manual is used to ensure consistency in intervention delivery across all intervention groups. Counseling is provided after the baseline assessment and before initiation of anti-tuberculosis treatment. Each session is conducted in a private counseling room and lasts approximately 30-45 minutes.

干预措施: psychosocial counseling (Other)

Control group

No Intervention

control group will only received standard services from PHC

结局指标

主要结局

Treatment adherence

时间窗: 2 months after intervention

Treatment adherence will be assessed at the two-month follow-up using treatment records maintained by the primary health care centers and a treatment adherence card completed by participants throughout the intensive treatment phase. Adherence will be defined as the extent to which participants follow the prescribed anti-TB treatment regimen during the first two months of therapy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zahroh Shaluhiyah

Professor

Universitas Diponegoro

研究点 (1)

Loading locations...

相似试验